Apolipoprotein E4 (ApoE4) has been identified as a significant genetic risk factor for late-onset Alzheimer’s disease, as it has been associated with reduced BDNF levels [130] and inhibited BDNF mRNA expression [131]. This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.